Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta-Analysis

Table 1

Characteristics of included studies.

Author (reference)	Published year	Cases T/C	Age (years); Range, mean		Sex; Male/female	Course of disease (years); Range, mean
Tang et al. [14]	2013	50/50	T: 24–65, 41.2; C: 23–67, 42.1		T: 37/13; C: 38/12	T: 0–0.7, 0.4; C: 0–0.8, 0.4
Chen and Tu [15]	2013	30/20	NR		T: 20/10; C: 15/5	NR
Wu [16]	2012	45/45	T: 33–68, 47.9; C: 34–66, 48.4		T: 26/19; C: 23/22	T: 1–6, 3.4; C: 1–7, 3.1
Xu et al. [17]	2011	30/30	T: 18–53, 42.2; C: 16–58, 45.3		T: 18/12; C: 20/10	T: 0.1–3; C: 0.1–3.2
Zhu [18]	2010	45/45	T: 22–75, 44.6; C: 34–68, 46.1		T: 20/25; C: 22/23	T: 0.1–0.4; C: 0.1–0.3
He et al. [19]	2008	32/28	T: 16–61, 32; C: 17–59, 31		T: 19/13; C: 16/12	NR
Xie et al. [20]	2008	30/30	T: 22–61, 38.5; C: 19–65, 42.1		T: 22/8; C: 20/10	T: 0.1–6, 4.5; C: 0–10, 4.7
Shu [21]	2007	24/24	19–53	T: 36.2; C: 37.8	T: 20/4; C: 18/6	T: 0.2; C: 0.2
Li [22]	2006	32/31	T: 37.1; C: 37.3		T: 22/10; C: 17/14	T: 0.1; C: 0.1
He et al. [23]	2003	121/117	NR		NR	NR
He* et al. [24]	2003	312/104	T: 39.8; C: 41.3		T: 233/79; C: 80/24	T: 0.1^a, 3.1^ch; C: 0.1^a, 3.3^ch

T: trials group, C: control group. NR: no report. ^aacute cholestatic hepatitis, ^chchronic cholestatic hepatitis.
“∗” in Table 1 and Table 2 refers to another study different from the study of the same name and year’